267 related articles for article (PubMed ID: 11294697)
1. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
Ferreira A; Bettencourt P; Dias P; Pestana M; Serrão P; Soares-da-Silva P; Cerqueira-Gomes M
Clin Sci (Lond); 2001 May; 100(5):557-66. PubMed ID: 11294697
[TBL] [Abstract][Full Text] [Related]
2. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
Pimenta J; Pereira M; Castro A; Dias P; Azevedo A; Bettencourt P; Ferreira A
Rev Port Cardiol; 2002 Feb; 21(2):157-62. PubMed ID: 11963285
[TBL] [Abstract][Full Text] [Related]
3. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
[TBL] [Abstract][Full Text] [Related]
4. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
Marenzi G; Lauri G; Assanelli E; Grazi M; Guazzi M; Berna G; Salvioni A; Agostoni P
Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
[TBL] [Abstract][Full Text] [Related]
5. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; de Faria DB
Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635
[TBL] [Abstract][Full Text] [Related]
6. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
[TBL] [Abstract][Full Text] [Related]
7. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
Kubo SH
Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
[TBL] [Abstract][Full Text] [Related]
8. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
Langes K; Bleifeld W
Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
[TBL] [Abstract][Full Text] [Related]
9. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
Bauersachs J; Fraccarollo D
Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
[TBL] [Abstract][Full Text] [Related]
11. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
[TBL] [Abstract][Full Text] [Related]
12. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
13. [Renin, aldosterone and prostaglandins in heart failure].
Riegger AJ
Z Kardiol; 1991; 80 Suppl 8():37-40. PubMed ID: 1796634
[TBL] [Abstract][Full Text] [Related]
14. [Role of prostaglandins in regulation of kidney function in heart failure].
Riegger AJ
Herz; 1991 Apr; 16(2):116-23. PubMed ID: 2066053
[TBL] [Abstract][Full Text] [Related]
15. The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure.
Ferreira A; Bettencourt P; Pimenta J; Friões F; Pestana M; Soares-da-Silva P; Cerqueira-Gomes M
Am Heart J; 2002 Mar; 143(3):391-7. PubMed ID: 11868042
[TBL] [Abstract][Full Text] [Related]
16. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Rademaker MT; Charles CJ; Nicholls MG; Richards AM
Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
[TBL] [Abstract][Full Text] [Related]
17. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
18. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
19. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure.
Al-Hesayen A; Parker JD
Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026
[TBL] [Abstract][Full Text] [Related]
20. Renal synthesis of dopamine in asymptomatic post-infarction left ventricular systolic dysfunction.
Ferreira A; Bettencourt P; Pestana M; Oliveira N; Serrão P; Maciel MJ; Cerqueira-Gomes M; Soares-da-Silva P
Clin Sci (Lond); 2000 Sep; 99(3):195-200. PubMed ID: 11787471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
